NCT06874205View on ClinicalTrials.gov

Assessment of 11C-JMJ-129 for Imaging PDE4D in Brain and Whole Body of Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

April 11, 2025

Primary Completion Date

February 22, 2028

Study Completion Date

February 5, 2029

Conditions

Healthy

Interventions

DRUG

11C-JMJ-129

Injected IV followed by PET scanning

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Institute of Mental Health (NIMH)

NIH